# Top 30 Medical Device Angel Investors in Israel in June 2026 ## Yehuda Zisapel - Type: Angel - Relevant deals: 2 - Stages: Series A, Seed - Focus: Medical Device, Medical, Health Care Mr. Yehuda Zisapel (EE,MSc, MBA, DHC) is the founder and president of the RAD-Bynet Group, a leading pioneering association of Israeli companies active in the development, production and marketing of innovative solutions for the data communications industry, and Chairman of RAD. The RAD-Bynet Group grew out of Bynet Data Communications, whichMr. Zisapel founded in 1975 as a small private company that marketed data communications products. Bynet represented major international vendors and was the first to introduce cutting-edge technologies into the Israeli market. Today, the Bynet Group is comprised of eight companies active in both the Israeli and Eastern European markets in such fields as systems integration, cabling, testing, outsourcing, and software development. Following the arrival of Mr. Zisapel’s brother, Zohar, who joined him in 1981, a wide range of industrial activity was spawned from within the newly established RAD, the first of the RAD Group companies. In the years following its successful launch, twenty-four additional independent hi-tech companies were opened to develop, produce and market a wide variety of advanced data communications products. ## Danny Hadar - Type: Angel - Relevant deals: 2 - Stages: Seed, Series B - Focus: Software, Artificial Intelligence, Internet For the last 10 years, I have been active within the Israeli and US startup ecosystems where I completed 20+ seed investments in companies such as Geoforce (acquired by LLR), Bonobo (acquired by Salesforce), Optitex (acquired by Efi), Keeprz (acquired by Como), Drippler (acquired by Soluto), Snyk (Unicorn) and few others. I am passionate for seedinvestments, creative ideas, risk taking and supporting entrepreneurs.Prior to that, I founded 2 companies, Blue Sky (Energy) and Sinusafe (Medical) after working as a software engineer for 7 years.I grew up in Israel, and lived in the US for 5 years while completing my MBA from Duke. I love all kinds of extreme sports, and particularly kite surfing and snowboarding. ## Shimon Eckhouse - Type: Angel - Relevant deals: 2 - Stages: Series B, Series C - Focus: Health Care, Medical Device, Medical Shimon Eckhouse, Ph.D., is a leading Israeli medical entrepreneur who has founded more than 20 startups including Syneron Medical Ltd., Lumenis Ltd., Ventor and Real-View Imaging. He is the current Chairman of Butterfly Medical Ltd, Active Chairman of Synerion Medical and serves as Executive of Matteris Ltd. Shimon Eckhouse served as the ChiefExecutive Officer of Syneron Medical Ltd. from April 17, 2013 to February 18, 2014. Shimon Eckhouse Co-Founded Colorchip Inc. in 2000 and served as its Chairman from 2003 to January 2004 and as Chief Executive Officer from 2001 to 2003. He served as the Chairman and Chief Executive Officer of ESC Medical Systems since its inception in 1992. He was also a co-founder and Chairman of Ventor Medical Technologies Ltd. He Co-Founded at Navotek Medical Ltd. Mr. Eckhouse took ESC public in 1996 and raised more than $250M in public offerings. He served as Chairman of Syneron Medical Ltd. from May 2004 to May 2013. He worked at Lumenis Ltd. Prior to that, Shimon Eckhouse served as Head of Product Development and Technical Director at Maxwell Technologies in San Diego, California. From 1969 to 1986, he worked at Rafael, Armament Development Authority of Israel as a Scientist, Team Leader and Head of Department and was active in various areas of research and development including lasers and electro-optics. Shimon Eckhouse has been the Founder of Orsense, Ventor, Tulip, Cardiodex, Opticul Diagnostic, C3D and NanoCyte, Inc. Shimon Eckhouse serves as the Chairman of Fluorinex Active Ltd. Shimon Eckhouse serves as the Chairman at Starling Advanced Communications Ltd. since July 2010. He serves as Chairman at OrSense Ltd. He also serves as the Chairman of the Board of Ossense Ltd., Navotek Medical Ltd., and Replicom Ltd. and Edge Medical Devices Ltd. He has been a Director at Syneron Medical Ltd. since May 2004. He serves as a Director of Cardiodex and NanoCyte, Inc. Shimon Eckhouse serves as a Member of Advisory Board of Agate Medical Investments LP and JGV Growth Equity Fund, L.P. Shimon Eckhouse serves as a Director of the Technion Israeli Institute of Technology. He served as a Director of Zend Technologies Ltd. He served as a Director of WideMed Ltd. Shimon Eckhouse has more than 25 registered patents and published more than 50 papers in leading reference journals and conferences. He holds a Ph.D. in Physics from the University of California at Irvine and a B.Sc. in Physics from the Technion Israeli Institute of Technology. ## Prof. Rafael Beyar - Type: Angel - Location: Haifa, Hefa, Israel - Relevant deals: 2 - Stages: Seed, Series A - Focus: Medical, Medical Device, Machine Learning Prof. Rafael Beyar ## Mazal CB - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Therapeutics, Medical Device Mazal CB ## Zohar Gilon - Type: Angel - Relevant deals: 2 - Stages: Seed, Series A, Series B - Focus: Software, Internet, Health Care Mr. Zohar Gilon is a Managing Partner at Tamar Technology Ventures. He has personally invested in over 45 start-ups and has achieved 13 exits. Mr. Gilon has also served as the Transaction Manager for some of Israel's most highly recognized exits and has managed each deal from inception through completion, including pricing and distributions.He has extensive investment experience including activity as an angel investor and an Investment Advisor to the Gilon Group. Mr. Gilon is a private investor in numerous high-technology companies, including affiliates of Radcom Ltd. in Israel. From 1974 to 1993, Mr. Gilon served as the President of various companies representing major U.S. aerospace and electronics corporations. From November 1993 to August 1995, he served as the President of W.S.P. Capital Holdings Ltd. Previously he served, as the Managing Director of Shaked Technologies Ltd. He serves as a Director of HCL CleanTech Ltd., RIT, AVT Ltd., Oberon Media, Inc., Edge Medical, Exlibris, OrSense Ltd., and WisAir Ltd. He served as a Director of RAD Ventures. Mr. Gilon served as a Director of RiT Technologies Ltd. since 1995, Ceragon Networks Ltd. since June 1999, Radware Ltd. from October 2006 to July 2009 and Radcom Ltd. since June 1995. He served as Member of the Supervisory Board of Advanced Vision Technology (AVT) Limited. He served as an Outside Director of Silicom Ltd. since 1994. ## Ron C - Type: Angel - Relevant deals: 2 - Stages: Seed, Pre-Seed - Focus: Health Care, Therapeutics, Medical Device Ron C ## Haim Chizic - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical Device, Clinical Trials, Health Diagnostics Haim Chizic is an individual investor. ## Daniel Koss - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical Device, Clinical Trials, Health Diagnostics Daniel Koss is an individual investor. ## Shmuel Cabilly - Type: Angel - Location: Rehovot, HaMerkaz, Israel - Relevant deals: 1 - Stages: Series B, Series C - Focus: Health Care, Medical, Artificial Intelligence Dr. Cabilly is a highly regarded scientist, an investor and an experienced Board Member of several companies. He is currently a Board Member of Medasense Biometrics Ltd. He previously worked for several companies including as the Co-Founder and a Chief Scientist of Ethrog Biotechnology which was sold to Invitrogen. Dr. Cabilly graduated fromthe Hebrew University (Ph.D., Immunology), and was a Post-Doctoral fellow at the City of Hope Research Institute heading a joint City of Hope/Genentech project where he developed a new technology for recombinant antibody production. This invention was patented in world patents “The old Cabilly” and “The New Cabilly patent”. Today there are already 20 drugs in the market based on this technology among which are Herceptin, Rituxan, Traceba, Raptiva, Xolair and more. ## Oren Dobronsky - Type: Angel - Location: Palo Alto, California, United States - Relevant deals: 1 - Stages: Seed, Series A, Angel - Focus: FinTech, Payments, Software Entrepreneur at heart. Angel investor in past two decades. I had the privilege to invest in the following startups, mostly at seed level: Houzz(Unicorn), TripActions(Unicorn), Hippo(Unicorn), HomeLight, Domestika, Loop Commerce, RedKix, Duda, YouNow, OwnerListens... But mostly, I am known as Oren from Oren's Hummus :) ## Shahar Tzafrir - Type: Angel - Relevant deals: 1 - Stages: Series A, Seed, Series B - Focus: Artificial Intelligence, Software, Biotechnology Shahar is a Managing Partner at TLV Partners, investing in the idea/seed stage. Over the past decade, he has focused on the intersection of AI as it addresses commercial problems across sectors, including Developer Tools, Biotech, Cloud Native, Construction, Customer Retention, Data Centers, Drug Discovery, Enterprise Software, Health Care,and Taxes.His investment portfolio at TLV Partners includes Buildots, Bond (acquired by Reef), Canopy Immuno-Therapeutics, Covver, Churney, Deepcure, EverAfterAI, Gelt, Granulate (acquired by Intel), Guesty (exit via secondary), Immunai, Odo (acquired by Checkpoint), ScyllaDB, Solvo, Silverfort, and Unleash. He also serves as a Board Observer at Aidoc on behalf of the founders.Before joining TLV Partners, Shahar was a General Partner at Magma Venture Partners, working with funds III and IV. His investment portfolio included Aidoc, Applitools (acquired by Thoma Bravo), Cloudendure (acquired by Amazon), Coretigo, Guesty (exit via secondary), Indegy (acquired by Tenable), ScyllaDB, Syte, Teridion, and Tonkean.Before his venture capital career, Shahar spent 15 years across three startups: Federation (acquired by Cordys), Oblicore (acquired by CA), and DigitalFuel (acquired by VMWare).He served as a software programmer in Israel’s Defense Forces for six years, earning three annual distinction awards at the Unit, Division, and Corps levels.He holds an LL.B., graduating Summa Cum Laude as the Valedictorian. Outside work, he is an amateur nature photographer and a chess player interested in Advanced Chess, a blend of AI and human strategy. ## Zohar Zisapel - Type: Angel - Location: Tel Aviv, Tel Aviv, Israel - Relevant deals: 1 - Stages: Series A, Seed, Series B - Focus: Cyber Security, Security, Software Zohar Zisapel ## Avi Kornreich - Type: Angel - Relevant deals: 1 - Stages: Series A - Focus: Medical, Hospital, Health Care Avi Kornreich is a former CEO of Agentek. ## Tzachi Arabov - Type: Angel - Relevant deals: 1 - Stages: Seed - Focus: Medical Device, Clinical Trials, Health Diagnostics Tzachi Arabov is a owner of ACRO. ## Jim Elkind - Type: Angel - Relevant deals: 1 - Stages: Series A - Focus: Medical, Hospital, Health Care Jim Elkind is a private healthcare investor. ## Lewis Pell - Type: Angel - Location: Horsham, Pennsylvania, United States - Relevant deals: 1 - Stages: Post-IPO Equity - Focus: Health Care, Medical, Therapeutics Lewis Pell was appointed to our Board of Directors and was unanimously elected to serve as Non-Executive Chairman of the Board on December 12, 2011. Pell was a member of Radiancy’s Board since 1998. Pell has founded over a dozen successful medical technology companies during the past three decades. In 1979, he founded Pentax PrecisionInstruments, which was sold to Asahi Optical Co. in 1990. In 1983, he founded American Endoscopy Inc., which was sold to C.R. Bard, Inc. (BCR-NYSE) in 1986. In 1984, he founded Versaflex Inc., which was sold to Medtronic in 1988. In 1989, he founded Heart Technology Corp., which went public in the U.S. in 1992 and was sold to Boston Scientific Corp. (BSX-NYSE) in 1995. In 1991, he founded InStent Inc., which became a public company in 1995 and was sold to Medtronic in 1996. In 1994, he founded Influence Inc., which was sold to American Medical Systems Inc. in 1999. Working with Shlomo Ben-Haim, Pell founded Biosense Inc. in 1994, which was sold to Johnson & Johnson in 1997. He is currently chairman and an investor for a number of private medical device companies. In 1992, he founded and remains the chairman of Vision-Sciences, Inc. (VSCI-NASDAQ). Pell has a B.S. in political science from Brooklyn College and over 20 years of experience in the medical technology industry. Pell was selected to serve on the Company’s board because of his over thirty-years’ experience in leadership roles in the medical device industry. ## Michal Efrat Zarfati - Type: Angel - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Wearables, Medical Device, Rehabilitation Michal Efrat Zarfati ## Jeremy Coller - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Pre-Seed, Series A - Focus: News, Video, Mobile Jeremy Coller founded the business in 1990.Prior to this, Jeremy spent five years at Imperial Chemical Industries (ICI) Investment Management, where he pioneered the acquisition of private equity secondaries.He began his career as a public equities investment analyst at Fidelity International Investment Management in London.Jeremy holds aBSc (Hons) in Management Sciences from the University of Manchester, UMIST; an MA in Philosophy from Sussex University; and a Diplôme Cours de Civilisation from the Sorbonne. He attended Carmel College. ## Marius Nacht - Type: Angel - Location: Tel Aviv-yafo, Tel Aviv, Israel - Relevant deals: 1 - Stages: Series A, Seed - Focus: Artificial Intelligence, Health Care, Machine Learning Marius Nacht, one of Check Point’s founders, has served as Chairman of our board of directors since 2015. Nacht has also served as one of our directors since we were incorporated in 1993. From 1999 through 2005, Nacht held Senior Vice President roles at Check Point. Nacht earned a B.S. (cum laude) in Physics and Mathematics from the HebrewUniversity of Jerusalem in 1983, and an M.S. in Electrical Engineering and Communication Systems from Tel Aviv University in 1987. ## Jacques R. Seguin - Type: Angel - Location: London, England, United Kingdom - Relevant deals: 1 - Stages: Seed, Pre-Seed - Focus: Medical, Medical Device, Health Care Jacques Seguin is the Chairman Of The Board at Emanate Biomedical. He Attended Paris-Sud University (Paris XI) during 1975-1985. ## Ran Tuttnauer - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Big Data, Internet Ran Tuttnauer ## Itsik Danziger - Type: Angel - Relevant deals: 1 - Stages: Series A - Focus: Medical, Hospital, Health Care Itsik Danziger - Chairman of the Board @ The Center for Educational Technology (CET) ## Moshe Yanai - Type: Angel - Location: Brookline, Massachusetts, United States - Relevant deals: 1 - Stages: Seed, Series B, Series D - Focus: Data Storage, Artificial Intelligence, Medical Moshe Yanai has been instrumental in the development of some of the most advanced and successful storage technologies in the history of the industry. Mr. Yanai began his career in the 1970s, building IBM-compatible mainframe storage based on minicomputer disks. He went on to develop high-end storage systems for Nixdorf, and in the late 1980s,joined EMC, leading the team that developed Symmetrix (today’s “DMX series”). As Vice President of EMC’s Symmetrix group, Mr. Yanai was responsible for design and development of all hardware and software products for EMC’s industry-leading enterprise storage systems. Based in Hopkinton, Massachusetts, EMC’s Symmetrix group grew from only one employee in 1987 to more than 3500 under his leadership. Mr. Yanai graduated in 1975 from the Technion, Israel Institute of Technology with a Bsc in Electrical Engineering. He holds over 40 patents for various innovative storage hardware and software-related technologies. ## Moshe Gaon - Type: Angel - Relevant deals: 1 - Stages: Seed, Series A, Convertible Note - Focus: Advertising, SaaS, Music Business entrepreneur and investor in startups. For the past 20 years developer of new initiatives and ideas. CEO, Chairman of companies, political strategist and advertising expert. Lead public opinion campaigns for people and issues from breast cancer, to national elections to the Israeli-Palestinian peace negotiations. Founding Partner atmybulb.vcOwner of the Gaon Holding Group; Executive Director in the group's companies, focusing on development and marketing products and services for the global Water Smart Grid. Member of the AquaAgro Fund Investment committee, a 50 Million dollar Israeli Venture Capital Fund, focused only on developing innovative water and agriculture technologies, as well as other innovative clean technologies. ## Benny Levin - Type: Angel - Relevant deals: 1 - Stages: Series A - Focus: Medical, Hospital, Health Care Benny Levin is a founder and former CEO of NICE. ## Rafi Gidron - Type: Angel - Relevant deals: 1 - Stages: Seed, Angel, Pre-Seed - Focus: Artificial Intelligence, Cyber Security, Software Rafi Gidron is the Founder and Chairman of Israel Brain Technologies. He previously worked at Lucent as a VP of Optical networks. Rafi Gidron attended Columbia University. ## Amir Gross - Type: Angel - Relevant deals: 1 - Focus: Medical, Health Care, Medical Device Amir Gross is the CEO of Cardiovalve. ## Shane Neman - Type: Angel - Location: Miami, Florida, United States - Relevant deals: 1 - Stages: Seed, Series A - Focus: Health Care, Software, Artificial Intelligence Founder of EZ Texting and JoonBug. Serial entrepreneur and investor in Tech, Real Estate & Hospitality.cA forward-thinking problem solver, consummate optimist and serial entrepreneur, Shane Neman is the prototypical businessman of our modern era. His experience and expertise in business span numerous industries, from technology andtelecommunications to real estate and hospitality. After leaving NYU Medical School early, he started three industry-shifting tech startups (two of them – EZ Texting and JoonBug – acquired) with hundreds of employees and tens of thousands of customers. As an insightful startup backer, Shane’s portfolio includes companies such as Convoy, Prose, Impossible Foods, Universal Standard, Apostrophe, MeetMindful, MapAnything, VinePair and Smylen. Shane is also a prolific real estate developer and investor. From commercial shopping and industrial centers to residential buildings, he owns more than two dozen large-scale properties across the U.S. He holds a degree in Computer Science from New York University, where he received the prestigious Barry M. Goldwater scholarship and was a member of the Phi Beta Kappa academic honor society. ## Alan Patricof - Type: Angel - Location: New York, New York, United States - Relevant deals: 1 - Stages: Series A, Seed - Focus: Finance, Financial Services, FinTech Alan Patricof is the founder and Chairman Emeritus and was a managing director of Greycroft. He is a Co-founder and Chairperson at Primetime Partners and was a Founder at Apax Partners. Alan attended Columbia Business School and The Ohio State University.